Topical skin preparation
The use of Lavandula extract in skin preparations addresses stability and effectiveness issues, improving skin tone by inhibiting melanin production and enhancing skin brightness, offering a stable and effective natural solution.
Patent Information
- Application Number
- JP2023205648
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-10
- Filing Date
- 2023-12-05
- Publication Date
- 2024-11-21
AI Technical Summary
Existing skin care products using natural ingredients face issues with stability and effectiveness in improving skin tone, particularly due to problems with coloration, odor, and inefficacy over time.
An external skin preparation containing an extract of white flowers from the Lavandula genus in the Lamiaceae family, utilizing extraction methods such as immersion or supercritical extraction with hydrophilic solvents like water, lower alcohols, or polyhydric alcohols, and combining it with other ingredients to enhance stability and effectiveness.
The extract effectively improves skin tone by inhibiting tyrosinase activity, suppressing melanin production, and enhancing skin brightness and transparency, while maintaining stability over time.
Smart Images

Figure 2024162980000001 
Figure 2024162980000002 
Figure 2024162980000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an external skin preparation containing an extract of a plant of the genus Lavandula in the family Lamiaceae, which has excellent stability and effectiveness, as an active ingredient, and a method for evaluating skin tone. [Background technology]
[0002] Skin aging or disorders is a phenomenon that occurs due to a complex intertwining of internal factors such as inactivation of cell proliferation and differentiation, decreased hormone secretion, and quantitative decrease in extracellular matrix components with aging, and external factors such as cell and tissue damage or inflammation caused by active oxygen induced by ultraviolet rays and air pollutants. Examples of skin aging or disorders include wrinkles, sagging, loss of elasticity, decreased barrier function of the skin, pigmentation or dullness, etc., and wrinkle improving agents, moisturizing agents, and age spot prevention agents have been proposed according to each skin condition.
[0003] Conventionally, antioxidants such as vitamins A and E and moisturizers (e.g., amino acids, organic acids, hyaluronic acid or its salts, chondroitin, heparinoids, etc.) have been proposed as ingredients for preventing and improving skin aging or disorders, but they have problems in terms of stability and effectiveness. In addition, the use of ingredients derived from natural products such as plants has also been proposed, but there are problems in terms of stability over time (coloration, sediment, odor, etc.) and effectiveness. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] Japanese Patent Application Publication No. 09-136824 [Patent Document 2] Japanese Patent Publication No. 11-335233 [Patent Document 3] Patent Publication No. 2015-028012 DISCLOSURE OF THEINVENTION [Problem to be solved by the invention]
[0005] In view of the problems of the conventional techniques, the present inventors have conducted extensive research to find new active ingredients derived from natural products that are safe for the skin. As a result, they have found that an extract from the white flowers of a plant of the genus Lavandula in the family Lamiaceae has the effect of improving skin tone.
[0006] Conventionally, it has been disclosed, for example, in Patent Documents 1 to 3, that extracts from plants of the genus Lavandula have skin physiological activity. However, it was not known that extracts from white flowers of plants of the genus Lavandula have the effect of improving skin tone. [Means for solving the problem]
[0007] The present invention relates to an external skin preparation containing, as an active ingredient, an extract from the white flowers of a plant belonging to the genus Lavandula of the family Lamiaceae. Effect of the Invention
[0008] The present invention relates to an external skin preparation containing, as an active ingredient, an extract of a white flower of a plant belonging to the genus Lavandula of the family Lamiaceae. According to the present invention, an external skin preparation that improves skin tone can be provided. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] Examples of plants of the genus Lavandula in the family Lamiaceae used in the present invention include English lavender (Lavandula angustifolia), French lavender (Lavandula stoechas), and hybrids thereof.
[0010] As the part of the plant belonging to the genus Lavandula used in the present invention, the use of white flowers is particularly preferable from the viewpoints of stability and effectiveness.
[0011] The preparation of the extract is carried out by first washing the part to be used for extraction with water if necessary to remove foreign matter, leaving it as it is or drying it, and then cutting or crushing it as necessary, and contacting it with an extraction solvent to carry out extraction. The extraction can be carried out by contacting it with an extraction solvent according to a conventional method such as the immersion method, but it is also possible to use a supercritical extraction method other than the immersion method.
[0012] Examples of extraction solvents include water; lower alcohols such as methanol, ethanol, and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin; esters such as ethyl acetate, butyl acetate, and methyl propionate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; and hydrocarbon solvents such as n-hexane, toluene, and chloroform, and these may be used alone or in combination of two or more.
[0013] Among these extraction solvents, hydrophilic solvents such as water, lower alcohols, or polyhydric alcohols are preferred in the present invention from the viewpoints of the effectiveness of the extract obtained, furthermore skin irritation, and also because they can be widely applied to skin external preparations (cosmetics, quasi-drugs, external medicines, etc.).Preferred examples of the hydrophilic solvent include the use of water, lower alcohols (particularly ethanol), or polyhydric alcohols (particularly 1,3-butylene glycol, glycerin) alone, or a mixed solvent of water and lower alcohols (particularly ethanol), or a mixed solvent of water and polyhydric alcohols (particularly 1,3-butylene glycol, glycerin), etc.
[0014] When a mixed solvent is used, the mixing ratio, for example, of water and a lower alcohol or a polyhydric alcohol, is preferably 1:5 to 25:1 in terms of volume ratio (the same applies below).
[0015] The weight ratio of the part of the plant to be used to the extraction solvent is preferably 1:1 to 1:50.
[0016] In preparing the extract, the pH is not particularly limited, but is generally preferably in the range of 3 to 9. In this sense, if necessary, an alkalinity regulator such as sodium hydroxide, sodium carbonate, or potassium hydroxide, or an acidity regulator such as citric acid, hydrochloric acid, phosphoric acid, or sulfuric acid may be added to the extraction solvent to adjust the pH to a desired level.
[0017] The extraction conditions such as extraction temperature and extraction time vary depending on the type and pH of the solvent used. For example, when water alone or a mixture of water and a lower alcohol or a polyhydric alcohol is used as the solvent, the extraction temperature is preferably in the range of 0°C to 80°C, and the extraction time is preferably in the range of 1 to 168 hours (1 hour to 1 week), and more preferably in the range of 1 to 120 hours (1 hour to 5 days).
[0018] In order to remove impurities and improve stability, the extract of the present invention may be subjected to one or a combination of two or more of activated carbon treatment, ion exchange resin treatment, synthetic adsorbent treatment, silica gel, and recrystallization treatment to remove impurities other than the active ingredients.
[0019] The extract prepared as described above may be used as an ingredient in a skin external preparation as it is after adjusting the pH to 3 to 8, or may be used at a desired concentration by concentrating under reduced pressure, etc. The extract may also be dried by a conventional method such as spray drying.
[0020] As shown in the examples below, the extract according to the present invention has an effect of improving skin tone. The effect of improving skin tone includes "brightening skin tone," "improving dull skin," "preventing pigmentation," and "improving skin transparency."
[0021] Examples of topical skin preparations (cosmetics, quasi-drugs, or topical pharmaceuticals) containing the extract of the present invention include, but are not limited to, milky lotions, creams, lotions, essences, packs, lipsticks, foundations, sheet masks, liquid foundations, makeup press powders, blushers, face powders, facial cleansers, body shampoos, soaps, and other cleansing cosmetics, as well as bath additives.
[0022] The amount of the extract according to the present invention to be blended in a skin care topical preparation is generally in the range of 0.00001 to 5.0% by weight (solid content weight %, the same applies below) as the solid content of each extract, and when blended in a cleansing topical preparation, generally in the range of 0.00001 to 5.0% by weight as the solid content of each extract.
[0023] When the extract according to the present invention is incorporated into an external preparation for skin (a cosmetic, a quasi-drug, or an external medicine), ingredients used in external preparations for skin, such as oily ingredients, surfactants (synthetic or natural), moisturizers, thickeners, emulsifiers or emulsification aids, preservatives / bactericides, powder ingredients, UV absorbers, antioxidants, sequestering agents, pigments, fragrances, anti-wrinkle agents, pigmentation prevention agents, and other physiologically active ingredients, can be appropriately incorporated as necessary.
[0024] Examples of oily components include olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, coconut oil, palm oil, cocoa oil, meadowfoam oil, shea butter, tea tree oil, avocado oil, macadamia nut oil, bergamot oil, lavender oil, rose oil, bergamot oil, chamomile oil, and other plant-derived oils and fats such as squalane; vitamin A oil; animal-derived oils and fats such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, and lanolin; liquid paraffin, petrolatum, and paraffin wax. and squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, and cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, pantothenyl alcohol, and stearyl alcohol; synthetic esters and synthetic triglycerides such as isopropyl myristate, isopropyl palmitate, butyl oleate, 2-ethylhexyl glyceride, and higher fatty acid octyldodecyl (e.g., octyldodecyl stearate).
[0025] Examples of the surfactant include nonionic surfactants such as polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyoxyethylene hydrogenated castor oil, and polyoxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene Examples of the surfactants that can be used include anionic surfactants such as quaternary ammonium salts, primary to tertiary fatty amine salts, trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts, N,N-dialkylmorpholinium salts, and polyethylene polyamine fatty acid amide salts; and amphoteric surfactants such as N,N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N,N,N-trialkyl-N-alkyleneammoniocarboxybetaine, N-acylamidopropyl-N', N'-dimethyl-N'-β-hydroxypropylammoniosulfobetaine.
[0026] Examples of emulsifiers or emulsification aids that can be blended include stevia derivatives such as enzyme-treated stevia, saponin or its derivatives, casein or its salts (sodium, etc.), sugar and protein complexes, sucrose or its esters, lactose, soy-derived water-soluble polysaccharides, soy-derived protein and polysaccharide complexes, lanolin or its derivatives, cholesterol, stevia derivatives (enzyme-treated stevia, etc.), silicates (aluminum, magnesium, etc.), carbonates (calcium, sodium, etc.), saponin and its derivatives, lecithin and its derivatives (hydrogenated lecithin, etc.), lactic acid bacteria-fermented rice, lactic acid bacteria-fermented germinated rice, lactic acid bacteria-fermented grains (wheat, beans, millet, etc.), etc.
[0027] Examples of moisturizing agents include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and the like, as well as sugars such as trehalose and raffinose, mucopolysaccharides (e.g., hyaluronic acid and its derivatives, hyaluronic acid fermentation liquid, chondroitin and its derivatives, heparin and its derivatives, etc.), elastin and its derivatives, collagen and its derivatives, collagen peptides, NMF-related substances, lactic acid, urea, higher fatty acids octyldodecyl, seaweed extracts, estradiol, various amino acids and their derivatives.
[0028] Examples of thickening agents include components derived from brown algae, green algae, or red algae, such as alginic acid, agar, carrageenan, and fucoidan; polysaccharides such as pectin, pullulan, and aloe polysaccharides; gums such as tragacanth gum, locust bean gum, xanthan gum, and guar gum; cellulose derivatives such as carboxymethyl cellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose; synthetic polymers such as carboxyvinyl polymers, alkyl-modified carboxyvinyl polymers, polyvinyl alcohol, polyvinylpyrrolidone, and acrylic acid-methacrylic acid copolymers; hyaluronic acid and its derivatives; polyglutamic acid and its derivatives, and polyacrylic acid.
[0029] Anti-inflammatory agents include allantoin, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, β-glycyrrhetinic acid, stearyl glycyrrhetinate, ε-aminocaproic acid, d-camphor, dl-camphor, zinc oxide, panthenol, pyridoxine hydrochloride, and riboflavin or a derivative thereof.
[0030] Examples of preservatives and disinfectants include urea; benzoic acid or its salts, paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzalkonium chloride, salicylic acid, sodium salicylate, zinc pyrithione, benzalkonium chloride, ethanol, undecylenic acid, phenols, and alkane bromide. These include kilisoquinolinium, resorcinol, jamal (imidazolidinyl urea), isopropyl methylphenol, triclosan, trichlorocarbanide, trichlorohydroxydiphenol ether, hinokitiol, 1,2-pentanediol, propanediol, concentrated benzalkonium chloride solution 50, essential oils such as peppermint oil and eucalyptus oil, bark distillate, fermented radish liquid, ethanol derived from plants such as sugar cane and corn, or 1,3-butylene glycol.
[0031] Examples of cell activators include pantothenyl alcohol, menthol, dl-menthol, and γ-oryzanol.
[0032] Anti-acne agents include sulfur, salicylic acid or its salts, photosensitizer No. 201, pyridoxine dicaprylate, and the like.
[0033] Examples of powder components include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, cellulose-based powder, powder of grains (rice, wheat, corn, millet, etc.), powder of beans (soybeans, adzuki beans, etc.), etc.
[0034] Examples of ultraviolet absorbers include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and its derivatives, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-tert-butyl-4-methoxybenzoylmethane, 2-(2-hydroxy-5-methylphenyl)benzotriazole, urocanic acid, ethyl urocanate, and aloe extract.
[0035] Examples of antioxidants include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, carotenoids such as astaxanthin, vitamin E and its derivatives (for example, tocopherol acetate, tocopherol nicotinate), vitamin A and its derivatives (retinol palmitate, etc.).
[0036] Examples of sequestering agents include disodium edetate, trisodium edetate, tetrasodium edetate, etidronic acid or a salt thereof (e.g., tetrasodium etidronic acid), gluconic acid or a salt thereof (e.g., sodium gluconate), diethylenetriaminepentaacetic acid or a salt thereof (e.g., pentasodium diethylenetriaminepentaacetic acid), hydroxyethanediphosphonic acid or a salt thereof (e.g., tetrasodium hydroxyethanediphosphonic acid), and phytic acid or a salt thereof (e.g., sodium phytate).
[0037] Examples of pigmentation prevention agents include one or more selected from kojic acid or its derivatives, ascorbic acid or its derivatives, hydroquinone or its derivatives, ellagic acid and its derivatives, resorcinol derivatives, 4-methoxysalicylic acid potassium salt, vitamin E or its derivatives, nicotinic acid or its derivatives, magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), hydroxybenzoic acid and its derivatives, vitamin E and its derivatives, α-hydroxy acid, AMP (adenosine monophosphate, adenosine monophosphate), placenta extract, and linoleic acid.
[0038] Examples of the kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, and kojic acid dibutyrate, kojic acid ethers, and kojic acid sugar derivatives such as kojic acid glucoside. Examples of the ascorbic acid derivatives include sodium L-ascorbic acid 2-phosphate, magnesium L-ascorbic acid 2-phosphate, sodium L-ascorbic acid 2-sulfate, and sodium L-ascorbic acid 2-sulfate. Ascorbic acid ester salts such as magnesium ascorbic acid ester, ascorbic acid sugar derivatives such as L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid) and L-ascorbic acid-5-glucoside (5-O-α-D-glucopyranosyl-L-ascorbic acid), 6-acylated derivatives of these ascorbic acid sugar derivatives (the acyl group is a hexanoyl group, an octanoyl group, a decanoyl group, etc.), L-ascorbic acid tetraisopalmitate, L-ascorbic acid Examples of the hydroquinone derivatives include arbutin (hydroquinone-β-D-glucopyranoside) and α-arbutin (hydroquinone-α-D-glucopyranoside). Examples of the resorcinol derivatives include 4-n-butylresorcinol and 4-isoamylresorcinol. Examples of 2,5-dihydroxybenzoic acid derivatives include 2,5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, 2-hydroxy-5-propionyloxybenzoic acid, etc.; examples of nicotinic acid derivatives include nicotinamide and benzyl nicotinate; examples of vitamin E derivatives include vitamin E nicotinate and vitamin E linoleate; and examples of α-hydroxy acids include lactic acid, malic acid, succinic acid, citric acid, and α-hydroxyoctanoic acid.
[0039] Anti-wrinkle agents include vitamin A or its derivatives, vitamin E or its derivatives (tocopherol acetate, etc.), vitamin C or its derivatives (ascorbic acid glucoside, 3-O-ethyl ascorbic acid, magnesium ascorbyl phosphate, etc.), pantothenyl alcohol, tranexamic acid, and niacinamide.
[0040] Furthermore, it is also possible to use in combination components derived from natural products such as the following plants or microorganisms. For example, collagen or a hydrolysate thereof, yeast extract or hydrolysate, lactic acid bacteria culture, Gramineae plants, Cruciferae plants, Theaceae plants, Rosaceae plants, Paeoniaceae plants, Rutaceae plants, Amaranthaceae plants, Zosteraeae plants, Leguminosae plants, Asteraceae plants, Fabaceae plants, Malvaceae plants, Gentianaceae plants, Lamiaceae plants, Nelumbaceae plants, Cucurbitaceae plants, Araliaceae plants, Solanaceae plants, Bignoniaceae plants, Actinidiaceae plants, Mulberry plants, Iridaceae plants, Campanulaceae plants, Oleaceae plants, Actinidiaceae plants, Mulberry plants, Rhamnaceae plants, Orchidaceae plants, and Anacardiaceae plants. Examples of such extracts include extracts of one or more plants selected from the family Gardenia, Valenciaceae, Rutaceae, Myrtaceae, Liliaceae, Crassulaceae, Cupressaceae, Convolvulaceae, and Asparagaceae, or hydrolysates or fermented products thereof; extracts of one or more seaweeds selected from the family Laminaria, Laminaceae, and Ulvulaceae, or hydrolysates or fermented products thereof; jellyfish (autolyzed products of moon jellyfish, Nomura's jellyfish, etc.); hydrolysates or fermented products of hyaluronic acid; and extracts of royal jelly, or hydrolysates or fermented products thereof.
[0041] As the components derived from plants of the Gramineae family, in particular, hydrolyzed rice leaves, hydrolyzed rice extracts, hydrolyzed rice bran extracts, hydrolyzed germinated brown rice, fermented rice liquid, sake lees extracts derived from sake, and bamboo shoot skin extracts of Madake or Moso bamboo are preferred. As the components derived from plants of the Brassicaceae family, white mustard extracts or hydrolyzates thereof, and fermented white mustard are preferred. As the components derived from plants of the Theaceae family, in particular, green tea (Yabukita, Samidori, Asahi, Goko, Ujimidori, Kyomidori, Ujihikari, Samidori, Benifuki, etc.) and black tea (Darjeeling, Assam, Ceylon, Earl Grey, honey-scented black tea, etc.) are preferred. As the components derived from plants of the Rosaceae family, extracts of Damask rose flowers, extracts of peach flowers, leaves or immature fruits, extracts of strawberry flowers, extracts of cherry blossoms or leaves, and extracts of apricot fruits or seeds are preferred. As the component derived from a plant of the family Paeoniaceae, an extract of the root or flower of the peony and an extract of the flower or root of the peony are preferred. As the component derived from a plant of the family Amaranthaceae, an extract of Salicornia herbacea is particularly preferred. As the component derived from a plant of the family Zosteraea, an extract of Zostera marina or Zostera koa is particularly preferred. As the component derived from a plant of the family Fabaceae, an extract of white soybean or black soybean or a hydrolyzate thereof, or a fermented soy milk liquid, an extract of adzuki bean, an extract of red clover, and an extract of pueraria lobata root are particularly preferred. As the component derived from a plant of the family Asteraceae, an extract of burdock root, an extract of sunflower sprouts, an extract of Acanthus gracilis, an extract of Arnica officinalis, or an extract of chamomile flower are particularly preferred. As the component derived from a plant of the family Malvaceae, a fermented product of hibiscus, Rose of Sharon, or Hibiscus is preferred. As the component derived from a plant of the family Gentianaceae, an extract of gentiana is preferred. As the plant of the family Lamiaceae, an extract of perilla frutescens and an extract of the fruit of Acanthus purpurea are preferred. As the component derived from a plant of the Nelumbinaceae family, particularly preferred is a lotus flower or lotus seed extract or a fermented lotus seed product. As the component derived from a plant of the Cucurbitaceae family, particularly preferred is a loofah extract. As the component derived from a plant of the Araliaceae family, a ginseng extract or fermented product is preferred. As the component derived from a plant of the Solanaceae family, an extract of eggplant (long eggplant, water eggplant, rice eggplant, Kamo eggplant, etc.) is included. As the component derived from a plant of the Bignoniaceae family, a Pau d'Arco bark extract is preferred. As the component derived from a plant of the Actinidiaceae family, an unripe kiwi extract is preferred.As the component derived from a plant of the family Mulberry, extract of mulberry fruit, and extract of fruit or bark of fig are preferable. As the component derived from a plant of the family Rhamnaceae, extract of jujube fruit is preferable. As the component derived from a plant of the family Iridaceae, saffron is preferable. As the component derived from a plant of the family Campanulaceae, extract or hydrolysate of root of Codonopsis arvensis is preferable. As the component derived from a plant of the family Anacardiaceae, mango fruit extract is particularly preferable. As the component derived from a plant of the family Garcinia, mangosteen fruit extract is particularly preferable. As the component derived from a plant of the family Valenciaceae, cherimoya fruit extract is preferable. As the component derived from a plant of the family Rutaceae, extract of Satsuma mandarin, bergamot fruit, extract of grapefruit or Banpeiyu fruit (including immature fruit), extract containing flavonoids and their glycosides contained in plants such as grapefruit or Hassaku, or extract of Japanese pepper seed are preferable. As the component derived from a plant of the Liliaceae family, an extract of Daylily, Daylily, Casablanca, Madonna lily, or Lilium longiflorum is preferred. As the component derived from a plant of the Crassulaceae family, an extract or fermented product of Rhodiola rosea is particularly preferred. As the component derived from a plant of the Oleaceae family, an extract of Jasmine flower is particularly preferred. As the plant of the Cupressaceae family, an extract of Juniperus communis fruit is particularly preferred. As the component derived from a plant of the Myrtaceae family, an extract of guava leaf is particularly preferred. As the plant of the Orchidaceae family, an extract of Bletilla serrata root (white orchid) is particularly preferred. As the component derived from a plant of the Convolvulaceae family, an extract of sweet potato or a fermented product thereof, or an extract of sweet potato shochu lees or a fermented product thereof is preferred. As the component derived from a plant of the Asparagaceae family, an extract of asparagus is particularly preferred. As the component derived from Laminaceae seaweed, particularly preferred is Laminaria extract, as the component derived from Laminaceae seaweed, particularly preferred is Acanthus extract, as the component derived from Ulvaeaceae seaweed, particularly preferred is Ulva pertusa extract, as the component derived from Funoriaceae seaweed, particularly preferred is Funori extract.
[0042] The present invention will now be described in more detail with reference to Production Examples, Formulation Examples and Test Examples, but the present invention is not limited thereto. In the following, all parts are by weight and all % are by weight.
[0043] Preparation Example 1. Preparation of extract (1) Lavender flowers (white) belonging to the genus Lavandula in the family Lamiaceae were dried, and 400g of purified water and 600g of 1,3-butylene glycol were added to 100g of the dried product, followed by stirring for 2 hours at 40°C. The mixture was filtered, and purified water was added to adjust the concentration of 1,3-butylene glycol to 30%, yielding 1300g of a light brown, transparent lavender extract (solid content concentration 0.63%).
[0044] Preparation Example 2. Preparation of extract (2) The same process as in Production Example 1 was repeated except that lavender (Lavandula stoechas) flowers (white) were used instead of lavender (Lavandula angustifolia), to obtain 1,295 g of a light brown, transparent lavender extract (solid content concentration: 0.62%).
[0045] Preparation Example 3. Preparation of extract (3) 1000 g of purified water was added to 100 g of the dried product, and the mixture was stirred for 2 hours at 40° C. This was filtered to obtain 780 g of a light brown, transparent lavender extract (solid content concentration: 1.87%).
[0046] Comparative Example 1. Preparation of extract The same process as in Production Example 1 was repeated except that lavender (Lavandula angustifolia) flowers (purple) were used instead of lavender (Lavandula angustifolia) flowers (white), to obtain 1,305 g of a brown, transparent lavender extract (solid content concentration: 0.63%).
[0047] Comparative Example 2. Preparation of extract In the same manner as in Production Example 3, except that lavender (Lavandula angustifolia) flowers (purple) were used instead of lavender (Lavandula angustifolia) flowers (white), 775 g of a brown, transparent lavender extract was obtained (solid content concentration: 1.85%).
[0048] Test Example 1. Evaluation test of tyrosinase activity inhibition 6.0×10 vascular endothelial cells (HuVEC) 4 The cells / well were seeded on a 24-well plate, and after culturing in HuMedia MvG (Kurabo) medium for 24 hours, the extract of Production Example 1 was added as a sample solution. Here, the sample solution was prepared by adding the extract of Production Example 1 to HuMedia MvG (Kurabo) medium so that the final concentration of the solution was 0.5%, 1.0%, and 2.0%, respectively, to prepare three concentrations. After the addition of the sample solution, the cells were further cultured for 24 hours, and then UV-A (4,900 mJ / cm2) was irradiated from the bottom of the culture vessel. Then, the medium was removed with an aspirator and replaced with a medium not containing the sample solution. After the medium was replaced, vascular endothelial cells (HuVEC) were further cultured for 24 hours, and the culture supernatant was recovered (hereinafter referred to as the recovered culture supernatant A). Human normal melanocytes, which had been cultured in DermaLife M (Lifeline Cell Technology) medium separately from the vascular endothelial cell culture (HuVEC), were cultured at 1.5 × 10 4The cells were seeded in a 96-well plate so that the cells / well were 100 cells / well. After culturing normal human melanocytes for 24 hours, culture supernatant A was added as an evaluation sample. After culturing for 72 hours, the supernatant was removed, surfactant (Triton X-100) and 5 mM L-dopa solution were added and reacted at 37°C, and the dopa value was measured at a wavelength of 492 nm using a microplate reader (MULTISKAN FC, Thermo Scientific). In addition, a control group [UV-A(-) control] in which vascular endothelial cells (HuVEC) were cultured with a 30% butylene glycol aqueous solution of the same concentration instead of the sample solution and were not irradiated with UV-A, and a control group [UV-A(+) control] in which vascular endothelial cells (HuVEC) were cultured with a 30% butylene glycol aqueous solution of the same concentration instead of the sample solution and were irradiated with UV-A were set up, and the dopa value in each group was measured. The results of the tyrosinase activity evaluation test are shown as relative values for the dopa value in each group, with the dopa value in the UV-A(+) control group taken as 100.
[0049] The results of Test Example 1 are shown in Table 1. [Table 1] JPEG2024162980000001.jpg61132
[0050] First, as shown in Table 1, when the culture supernatant of vascular endothelial cells irradiated with ultraviolet light (culture supernatant without the extract of the present invention) was added to cultured melanocyte cells, the activity of the enzyme (tyrosinase) involved in melanin production was enhanced, whereas when the culture supernatant of vascular endothelial cells cultured with the extract of the present invention was added to cultured melanocyte cells, the tyrosinase activity was significantly suppressed. This suggests that the extract of the present invention has an effect of suppressing the release of tyrosinase activity enhancing factors from vascular endothelial cells by ultraviolet light irradiation, or an effect of promoting the release of melanin production inhibitory factors from vascular endothelial cells. In other words, it was confirmed by the above Test Example 1 that the extract of the present invention has a new effect of improving skin tone (improving skin transparency, improving skin brightness, preventing pigmentation, etc.) rather than a direct effect on melanocyte cells.
[0051] Furthermore, based on the above Test Example 1, the present invention can also provide a new evaluation method that can evaluate the effect of inhibiting tyrosinase activity, which affects skin tone, using vascular endothelial cells, rather than a method that directly uses melanocyte cells.
[0052] Test example 2. Visual color evaluation test The coloration of the extract of Production Example 1 was compared with that of the extract of Comparative Production Example 1. Three samples of each were prepared, left to stand at room temperature, 40° C., for one week, and visually observed.
[0053] The results of Test Example 2 are shown in Table 2. [Table 2] JPEG2024162980000002.jpg58153
[0054] As shown in Table 2, it was confirmed that the extract of Production Example 1 according to the present invention had a lighter color and showed less change over time in all three samples compared to the extract of Comparative Production Example 1. This shows that the extract of the present invention can suppress color change in the preparation when incorporated into an external skin preparation, and is particularly suitable for incorporation into transparent or white external skin preparations.
[0055] Test Example 3. Tyrosinase activity evaluation test 1.5×10 normal human melanocyte cells 4 The cells were seeded in a 96-well plate so that the cells were 1000 cells / well, and cultured in DermaLife M (LIFELINE CELL TECHNOLOGY) medium. After 24 hours of culture, a test group and a comparative test group were set, and the extract of Production Example 3 and the extract of Comparative Production Example 2 were added as sample solutions. Here, the sample solutions were prepared by adding the extract of Production Example 1 or the extract of Comparative Production Example 2 to DermaLife M (LIFELINE CELL TECHNOLOGY) medium so that the final concentrations as solutions were 0.5% and 1.0%, respectively, to the medium, and used. After 48 hours of culture, the supernatant was removed, and a surfactant (Triton X-100) and 5 mM L-dopa solution were added to react at 37°C, and the dopa value was measured at a wavelength of 492 nm using a microplate reader (MULTISKAN FC, thermo scientific). In addition, a control group was set up in which purified water was added instead of the sample solution, and the same operation was performed to measure the dopa value. The results of the evaluation test of tyrosinase activity are shown as relative values for each test group, with the dopa value for the control group taken as 100.
[0056] The results of Test Example 3 are shown in Table 3. [Table 3] JPEG2024162980000003.jpg69132
[0057] As shown in Table 3, it was confirmed that the extract according to the present invention (extract of Production Example 3) had a significant effect of inhibiting tyrosinase activity compared to the extract of Comparative Production Example 2.
[0058] Test example 4. Monitor test First, the following test was carried out on the lotion of the present invention, the comparative lotion and the control lotion shown in Table 4. That is, five randomly selected males and females aged 25 to 50 years were used as subjects, and three test areas were set up in which each lotion was applied to the forearm of each subject, and each lotion was applied twice a day (morning and evening) for four weeks. The subjects were then asked to self-evaluate (a) transparency, (b) usability (skin compatibility, stretchiness), and (c) texture on a four-point scale: A: very good, B: good, C: no change, D: slightly bad. The test results are shown in Table 5.
[0059] [Table 4] JPEG2024162980000004.jpg58164
[0060] [Table 5] JPEG2024162980000005.jpg91119
[0061] As shown in Table 5, the lotion of the present invention was more effective in improving (a) transparency, (b) usability (skin compatibility, spreadability), and (c) texture than the control lotion and comparative lotion, and the improvement in transparency was particularly notable.
[0062] Test Example 5. Evaluation of DKK1 (Dickkopf-1) Expression In Test Example 5, the expression of "DKK1" is evaluated, which is known to be a factor (protein) secreted from cells in the dermis and blood vessels that inhibits the Wnt signal pathway. Here, "DKK1" is known to inhibit the differentiation and proliferation of melanocytes present in the epidermis and to inhibit the synthesis of melanin by inhibiting the Wnt signal pathway (for example, as known in the non-public literature "Y. Yamaguchi, S. Itami, H. Watabe et al., J. Cell Biol., 165, 275-285
[2004] "). The test method is described in detail below. First, normal human microvascular endothelial cells (HMVEC) were placed in a 24-well plate at 1.0 × 10 5The cells were seeded at 1000 cells / well and cultured at 37°C under 5% CO2 and saturated steam. After 24 hours of culture, the sample solution was added and the cells were cultured for another 48 hours (test group). The sample solution was prepared by preparing the extract of Production Example 1 so that the final concentration of the solution was 2.0%. A control group was also prepared by adding 30% 1,3-butylene glycol instead of the sample solution and cultured in the same manner. Next, the cells in each test group and control group were collected with 0.5 mL of ISOGEN II reagent (manufactured by Nippon Gene Co., Ltd.). 200 μL of RNase-free water was added to the collected cells, which were stirred and mixed, and the cells were left at room temperature for 15 minutes, and then centrifuged for 15 minutes at 15,000 rpm and 4°C using a centrifuge (manufactured by TOMY Co., Ltd. / MX-160), and 500 μL of the supernatant was collected. 500μL of isopropanol (Wako Pure Chemical Industries, Ltd.) was added to the collected supernatant, stirred and mixed, left at room temperature for 10 minutes, and then centrifuged at 15,000 rpm and 4℃ for 10 minutes to obtain a total RNA precipitate. 0.5mL of 75% ethanol was added to the total RNA, and centrifuged at 15,000 rpm and 4℃ for 3 minutes to collect the precipitate. The supernatant was discarded, and this process was repeated twice. After completely removing the supernatant, the mixture was air-dried and dissolved in RNase-free water. The collected total RNA was reverse transcribed using a specified kit (PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time) [Takara Bio Inc.]) to synthesize cDNA. Using the synthesized cDNA as a sample, the expression of the DKK1 gene and the expression of the internal standard substance ACTB gene were detected using Thermal Cycler Dice (registered trademark) Real Time System Single (manufactured by Takara Bio Inc.) and SYBR (registered trademark) Premix Ex TaqTM II (Perfect Real Time) [manufactured by Takara Bio Inc.]. Here, ACTB (β-actin) is one of the housekeeping genes (a gene that is expressed in a constant amount in common in many tissues and cells, is constantly expressed, and is essential for the maintenance and proliferation of cells), and since its expression level is always constant, it is used as an internal standard in PCR experiments.The test results were obtained by comparing the expression level of the DKK1 gene in each test group when the expression level of the ACTB gene was kept constant.
[0063] The results of Test Example 5 are shown in Table 6. [Table 6] JPEG2024162980000006.jpg45124
[0064] As shown in Table 6, it was confirmed that the extract of the present invention suppresses the expression of DKK1 (Dickkopf 1). This suggests that the extract of the present invention has the effect of suppressing melanin production and improving skin tone (improving skin transparency, improving skin brightness, preventing pigmentation, etc.) by enhancing the expression of DKK1.
[0065] Test Example 6. Evaluation test of inhibition of inflammatory factor expression using membrane antibody array Normal human microvascular endothelial cells (HMVEC) were cultured in a 24-well plate at 1.0 × 10 5 The cells were seeded at 2,450 mJ / cm2 per well and cultured at 37°C under 5% CO2 and saturated water vapor. After 24 hours of culture, the evaluation samples were added and the culture was continued for another 24 hours. Then, UV-A was applied at 2,450 mJ / cm2. 2The cells were irradiated so that the concentration of 1,3-butylene glycol was 30% and the culture was continued for another 24 hours. As controls, a section in which 30% 1,3-butylene glycol was added at the same concentration without UV-A irradiation (unirradiated control) and a section in which 30% 1,3-butylene glycol was added at the same concentration after UV-A irradiation (irradiated control) were set. After the culture was completed, the supernatants were collected and the inflammatory cytokines in the supernatants were measured using Abcam's Cytokine Array-Human Cytokine Antibody Array (Membrane, 42 Targets). The measurement was performed as follows. After blocking was performed by treating the membrane included in the kit with blocking buffer for 30 minutes, the supernatant of the cultured extract of Production Example 1 was added and reacted overnight at 4°C. The next day, the membrane was washed, and the primary antibody solution was reacted at room temperature for 2 hours, washed with wash buffer, and the secondary antibody solution was added and left at room temperature for 2 hours. After the reaction, the membrane was washed with wash buffer, and detection buffer was applied to the membrane. The chemiluminescence images were taken with a cooled CCD camera (ATTO). The brightness of the images was used to calculate the values. At the same time, the control area was evaluated in the same manner, and the values detected in the unirradiated control area were set as 100, and the relative values were calculated.
[0066] The results of Test Example 6 are shown in Table 7. [Table 7] JPEG2024162980000007.jpg95149
[0067] As shown in Table 7, it was confirmed that the extract of the present invention suppresses the secretion of inflammatory cytokine factors (IL-10, TGF-β1, leptin, IL-15, IL-4, MCP-3, GCSF, IL-1β, IL-1α, TNF-α, IL-7) from vascular endothelial cells. This suggests that the extract of the present invention has the effect of suppressing the stimulation of melanocytes by inflammatory cytokine factors and improving skin tone (improving skin transparency, improving skin brightness, preventing pigmentation, etc.).
[0068] Test Example 7. Tyrosinase activity inhibition evaluation test It is also suggested that the extract according to the present invention, when combined with other active ingredients, may have a synergistic effect in improving skin tone (improving skin clarity, improving skin brightness, preventing pigmentation, etc.). In Test Example 3, the extract of Production Example 3 (three types of extracts adjusted to final concentrations of 0.5%, 1.0%, and 2.0% in the solution) and compositions containing 2 mM niacinamide (hereinafter referred to as "NA") or 1% (w / v%) ascorbic acid glucoside (hereinafter referred to as "AG") were prepared as sample solutions, and the tyrosinase activity inhibitory effect was evaluated in the same manner as in Test Example 3.
[0069] The results of Test Example 7 are shown in Table 8. [Table 8] JPEG2024162980000008.jpg74131
[0070] As shown in Table 8, it was confirmed that the extract of the present invention exhibits a significant tyrosinase activity inhibitory effect when combined with niacinamide or ascorbic acid glucoside in a concentration-dependent manner, suggesting that these combinations have a synergistic effect of improving skin tone (improving skin transparency, improving skin brightness, preventing pigmentation, etc.).
[0071] Test Example 8. Evaluation test of melanin production inhibition effect First, a sample solution to be used in Test Example 8 was prepared. That is, a composition containing the extract of Production Example 3 (an extract adjusted to a final concentration of 2.0% in solution) and 2% (w / v %) tranexamic acid (hereinafter referred to as "TX") was prepared as a sample solution. Next, a melanocyte-containing three-dimensional model MEL-300-A was pre-cultured according to the protocol, and then 50 μL of the sample solution was added to the stratum corneum and cultured for one day. Thereafter, the sample solution was aspirated and then UV-B was irradiated from above at 30 mJ / cm. 2The tissue was irradiated, and the sample solution was added again and cultured. The medium was replaced at that time. This operation was repeated a total of four times every 2 to 3 days during the culture period. After the culture was completed, the tissue was collected in a microtube, 1 mL of 10% DMSO-containing 1N NaOH solution was added, and the tissue was dissolved by boiling for 10 minutes, and the absorbance at 492 nm of the resulting solution was measured. The protein amount of the same solution was also measured by the Bradford method, and the amount of melanin per protein was calculated by dividing the absorbance at 490 nm by the amount of protein (mg / mL). In addition, a control group was set up using 1,3-butylene glycol of the same concentration instead of the sample solution by the same operation, and the relative value of the amount of melanin per protein in each sample-added group was calculated when the test group not irradiated with UV was set as 100.
[0072] The results of Test Example 8 are shown in Table 9. [Table 9] JPEG2024162980000009.jpg46124
[0073] As shown in Table 9, it was confirmed that the extract of the present invention, when combined with tranexamic acid, exhibits a significant effect of inhibiting melanin production, suggesting that this combination has a synergistic effect of improving skin tone (improving skin transparency, improving skin brightness, preventing pigmentation, etc.).
[0074] Formulation example 1. Lotion [Ingredients] Part Extract of Preparation Example 1 0.5 Squalane 0.2 Polyoxyethylene (5.5) Cetyl Alcohol 5.0 Tocopherol acetate 0.02 Dipotassium glycyrrhizinate 0.5 Monoammonium glycyrrhizinate 0.5 Isopropyl methylphenol 0.1 1,3-Butylene glycol 5.0 Sodium citrate 0.2 Methylparaben 0.1 Purified water (enough to make the total amount 100 parts)
[0075] Formulation example 2: Lotion A lotion was obtained in the same manner as in Formulation Example 1, except that 0.5 parts of the extract from Preparation Example 2 was used in place of 0.5 parts of the extract from Preparation Example 1.
[0076] Formulation example 3. Lotion A lotion was obtained in the same manner as in Formulation Example 1, except that 0.5 parts of the extract from Preparation Example 3 was used in place of 0.5 parts of the extract from Preparation Example 1.
[0077] Formulation example 4: Lotion [Ingredients] Part Extract of Preparation Example 1 1.0 Glyceryl Caprylate 3.0 Polyglyceryl-10 Laurate 3.0 Cetanol 2.0 Behenyl Alcohol 2.0 Niacinamide 5.0 Dipotassium glycyrrhizinate 0.1 Glycerin 1.0 1,3-Butylene glycol 1.0 Pentanediol 1.0 Potassium hydroxide 0.5 Purified water (enough to make the total amount 100 parts)
[0078] Formulation example 5. Lotion [Ingredients] Part Extract of Preparation Example 1 1.0 Jojoba oil 1.0 Polyoxyethylene (5.5) Cetyl Alcohol 5.0 Methylparaben 0.1 Ascorbic Acid Glucoside 2.0 Niacinamide 5.0 ε-Aminocaproic acid 0.1 Sulfur 0.2 Estradiol 0.1 Pyridoxine hydrochloride 0.5 Glycerin 5.0 1,3-Butylene glycol 5.0 Sodium citrate 0.2 Sodium pyrosulfite 0.1 d-Camphor 0.1 Purified water (enough to make the total amount 100 parts)
[0079] Formulation example 6. Emulsion [Ingredients] Part Extract of Preparation Example 1 2.0 Squalane 5.0 Cyclopentanesiloxane 1.0 Hexalan 3.0 Hexyldecyl Isostearate 1.0 Caprylic / Capric Triglyceride 1.0 Polyglyceryl-10 Laurate 5.0 Polyglyceryl-10 Isostearate 5.0 Ascorbyl Dipalmitate 15.0 Hydrogenated soy lecithin 1.5 Ascorbic acid phosphate magnesium salt 3.0 Arbutin 3.0 Potassium hydroxide 0.5 Glycerin 3.0 1,3-Butylene glycol 2.0 Carboxymethylcellulose 0.3 Xanthan gum 0.2 Tremella polysaccharide 0.2 Sodium hyaluronate 0.01 Tocopherol acetate 0.3 Tocopherol nicotinate 0.1 Glycyrrhizic acid 0.1 Dipotassium glycyrrhizinate 0.1 Isopropyl methylphenol 0.1 Water-soluble collagen 1.0 Hydrolyzed Collagen 1.0 Acetyl hyaluronic acid 0.1 Disodium edetate 0.05 Diethylenetriaminepentaacetic acid pentasodium 0.05 Purified water (enough to make the total amount 100 parts)
[0080] Formulation example 7. Emulsion An emulsion was obtained in the same manner as in Formulation Example 6, except that 2.0 parts of L-ascorbic acid-2-glucoside was used in place of 2.0 parts of magnesium ascorbyl phosphate.
[0081] Formulation example 8. Emulsion An emulsion was obtained in the same manner as in Formulation Example 6, except that 2.0 parts of tranexamic acid were used in place of 2.0 parts of magnesium ascorbyl phosphate and 2.0 parts of potassium hydroxide.
[0082] Formulation example 9. Emulsion An emulsion was obtained in the same manner as in Formulation Example 6, except that 3.0 parts of 3-O-ethyl ascorbic acid was used in place of 2.0 parts of magnesium ascorbyl phosphate among the ingredients of Formulation Example 6.
[0083] Formulation example 10. Emulsion An emulsion was obtained in the same manner as in Formulation Example 6, except that 2.0 parts of ascorbic acid phosphate magnesium salt and 3.0 parts of niacinamide were used in place of potassium hydroxide.
[0084] Formulation example 11. Cream [Ingredients] Part Olive oil 5.0 Squalane 5.0 Jojoba oil 5.0 Jojoba Wax 1.0 Behenyl Alcohol 1.0 Stearyl alcohol 1.0 Candelilla Wax 1.0 Lactic acid fermented rice 2.0 Soybean-derived hydrogenated lecithin 0.5 Extract of Preparation Example 1 1.0 Carboxyvinyl Polymer 1.0 Sodium alginate 1.0 Glycerin 2.0 Pentanediol 1.0 PH adjuster (appropriate amount) Purified water (enough to make the total amount 100 parts)
[0085] Formulation example 12. Cream [Ingredients] Part Extract of Preparation Example 1 1.0 Olive oil 5.0 Jojoba oil 5.0 Squalane 5.0 Hexyldecyl Isostearate 5.0 Di(octyldodecyl) lauroyl glutamate / phytosteryl / Behenyl) 5.0 Glyceryl Caprylate 1.0 Glyceryl stearate 1.0 Isostearyl glyceryl 3.0 γ-Oryzanol 0.1 Behenyl Alcohol 2.0 Palmitic acid 2.5 D-Pantothenyl alcohol 0.1 Allantoin 0.1 Riboflavin 0.01 Resorcinol 0.1 Benzalkonium chloride 0.05 Urea 3.0 β-Glycyrrhetinic acid 0.1 Stearyl Glycyrrhetinate 0.1 Ammonium glycyrrhizinate 0.1 Niacinamide 5.0 Lactic acid fermented rice 2.0 Hydrogenated lecithin 0.5 Hydrogenated lysolecithin 0.5 Hydrolyzed Collagen 1.0 Xanthan gum 1.0 Zinc oxide 0.5 dl-Camphor 0.3 l-Menthol 0.5 Purified water (enough to make the total amount 100 parts)
[0086] Example 13. Pack [Ingredients] Part Extract of Preparation Example 1 1.0 Dipropylene glycol 5.0 Polyoxyethylene (60) hydrogenated castor oil 5.0 Cetanol 3.0 Behenyl Alcohol 3.0 Allantoin 0.1 Dipotassium glycyrrhizinate 0.1 Ammonium glycyrrhizinate 0.1 β-Glycyrrhetinic acid 0.1 Stearyl Glycyrrhetinate 0.1 Salicylic acid 0.1 Tocopherol acetate 0.5 Tocopherol nicotinate 0.1 D-Pantothenyl alcohol 0.3 Resorcinol 0.1 Sulfur 2.0 Estradiol 0.002 Water-soluble collagen 1.0 Xanthan gum 2.0 Polyglyceryl-6 Myristate 1.0 Potassium cocoyl glutamate 1.0 Hydrogenated Lecithin 3.0 Hydroxylated Lecithin 3.0 Purified water (enough to make the total amount 100 parts)
[0087] Formulation example 14. Hair shampoo [Ingredients] Part Extract of Preparation Example 1 2.0 Sodium Laureth Sulfate 10.0 Glyceryl Monostearate 1.0 Coconut oil fatty acid diethanolamide 2.0 Polyoxyethylene (40) hydrogenated castor oil 0.5 Benzalkonium chloride 1.0 Stearyl Alcohol 2.0 Behenyl Alcohol 2.0 Dimethicone 3.0 Allantoin 0.1 Dipotassium glycyrrhizinate 0.1 Salicylic acid 0.1 Sodium Salicylate 0.1 Tocopherol acetate 0.1 Pyrithione Zinc 0.3 Benzoic acid 0.2 Triclosan 0.2 Citric acid 0.1 Propylene glycol 2.0 Purified water (enough to make the total amount 100 parts)
[0088] Formulation example 15. Hair conditioner [Ingredients] Part Extract of Preparation Example 1 1.0 Polyoxyethylene (10) hydrogenated castor oil 1.0 Distearyldimethylammonium chloride 1.5 Stearyltrimethylammonium chloride 2.0 Glyceryl 2-ethylhexanoate 1.0 Benzalkonium chloride 1.0 Cetanol 3.0 Stearyl alcohol 1.0 Allantoin 0.1 Isopropyl methylphenol 0.1 Dipotassium glycyrrhizinate 0.1 Salicylic acid 0.1 Sulfur 0.5 Alkylisoquinolinium bromide solution (75%) 0.06 Pyrithione Zinc 0.3 Methylparaben 0.1 Triclosan 0.2 Resorcinol 0.1 Purified water (enough to make the total amount 100 parts)
[0089] Formulation example 16. Cleansing cosmetics [Ingredients] Part Extract of Preparation Example 1 2.0 Potassium cocoyl glycine 5.0 Glycerin 10.0 Glyceryl Caprylate 1.0 Sodium lauroyl aspartate 10.0 Water-soluble collagen 1.0 Cetanol 3.0 Myristyl Alcohol 3.0 Isopropyl methyl alcohol 0.1 Allantoin 0.1 Sulfur 0.5 Glycyrrhizic acid 0.1 Dipotassium glycyrrhizinate 0.1 Monoammonium glycyrrhizinate 0.1 β-Glycyrrhetinic acid 0.05 Stearyl Glycyrrhetinate 0.1 Salicylic acid 0.2 Tocopherol acetate 0.2 Triclosan 0.1 Trichlorocarbanide 0.5 Trichlorohydroxydiphenyl ether 0.2 Concentrated benzalkonium chloride solution 50 0.2 Benzalkonium chloride 0.1 Purified water (enough to make the total amount 100 parts)
[0090] Formulation example 17. Sheet mask A sheet mask is obtained by impregnating a nonwoven fabric with the following components. [Ingredients] Part Extract of Preparation Example 1 1.0 Niacinamide 1.0 Citric acid 0.1 Sodium citrate 0.3 Xanthan gum 0.1 Water-soluble collagen 0.1 Sodium hyaluronate 0.01 Glycerin 1.0 1,3-Butylene glycol 2.0 Pentanediol 1.0 Potassium hydroxide (appropriate amount) Purified water (enough to make the total amount 100 parts)
[0091] Formulation example 18. Beauty serum [Ingredients] Part Extract of Preparation Example 1 2.0 Sodium hyaluronate 1.0 Water-soluble collagen 1.0 Tranexamic acid 0.1 Ethanol 2.0 Glycerin 5.0 1,3-Butylene glycol 5.0 Methylparaben 0.1 Citric acid 0.3 Sodium citrate 0.6 Eucheuma muscaria extract 5.0 Purified water (enough to make the total amount 100 parts)
[0092] Prescription example 19. Cream [Ingredients] Part Olive oil 5.0 Squalane 5.0 Jojoba oil 5.0 Jojoba Wax 1.0 Shea Butter 2.0 Behenyl Alcohol 1.0 Stearyl alcohol 1.5 Candelilla Wax 0.5 Niacinamide 1.0 Extract of Preparation Example 1 0.5 Lactic acid fermented rice 3.0 Hydrogenated Lecithin 2.0 Eucheuma muscaria extract 2.0 Carboxyvinyl polymer 0.3 Sodium alginate 0.2 Glycerin 4.0 Potassium hydroxide (appropriate amount) Purified water (enough to make the total amount 100 parts)
Claims
[Claim 1] A topical skin preparation containing an extract of the white flowers of a plant in the genus Lavandula, part of the Lamiaceae family, as its active ingredient.
Citation Information
Patent Citations
Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin
JP1997136824A
Melanogenesis inhibitor and cosmetic composition
JP1999335233A
Dendrite growth inhibitor and whitening skin cosmetics
JP2015028012A
